ECRINE POROCARCINOMA

Authors

  • Jad Abbas Chakhtoura Servicio de Anatomía Patológica, Hospital Dr. Calderón Guardia

Keywords:

Eccrine porocarcinoma, eccrine poroma, sweat glands, metastases, lymph nodes, Epithelial membrane antigen (EMA), carcinoembrionic antigen (CEA), p53, Cytokeratin

Abstract

Eccrine porocarcinoma is a rare type of skin cáncer arising from the intraepidermal portion of eccrine sweat glands, representing no more tan 0.01% of all cutaneous tumors. 20% of the Eccrine porocarcinoma will recur and 20% will metastasize to regional lymph nodes. Few cases of distant metastases has been reported . There is a mortality rate of 67% in patients with metastases. The diagnosis is primarily based on histopathologic findings and complementary immunohistochemistry for differential diagnosis mainly with more frequent skin cáncer. Neither chemotherapy nor radiation therapy has been proven to be of clinical benefit in treating this type of carcinoma. It is considered that the management should be based on surgical resection and electrochemotherapy.

References

1) Weedon, D. (2010). Weedon´s Skin Pathology, (Third ed). USA: Churchill LInvingstone. 804-5.

2) Mckee, P. , Calonje, J. E., et al. (2005). Pathology of the skin, (Third ed). USA: Mosby.

3) Yu, L., Olsen, S., et al. (2009, October). Fine needle aspiration cytology of metatatic eccrine porocarcinoma. Diagnóstic Cytopathology, 37, Issue 10, 755-58.

4) Sanz, M. E., Herrera, E., Arias, S., Castillo, J. y Arias, J. (2007). Porocarcinoma ecrino en una
paciente embarazada. Folia dermatol Perú, 18(2), 89-92.

5) Zeidan, et al. (2010). Treatment of eccrine porocarcinoma with metastasis to the parotid gland
using intensity-modulated radiation therapy: a case report. Journal of Medical Case Reports, 4,147.

6) Marone, U. & Corrado, C., et al. (2011). Metastatic eccrine porocarcinoma: report of a case and review of the literatura. World Journal of Surgical Oncology, 9, 32.

7) Kurisu, Y., Tsuji, M., et al. (2013, Aug). A case of Eccrine Procarcinoma: usefulness of immunostain for S-100 protein in the diagnosis of recurrent and metatatic dedifferentianted lesions. An Dermatol, 25(3), 348-351.

8) Robson, A., Greene, J., Ansari, N., Kim, B., Seed, P. T., McKee, P. H. & Calonje, E. (2001). Eccrine porocarcinoma (malignant eccrine poroma): A clinicopathologic study of 69 cases. Am J Surg Pathol, 25(6),710-720.

9) Akalin, T., Sen, S., Yuceturk, A. & Kandiloglu, G. (2001). p53 protein expression in eccrine poroma and porocarcinoma. Am J Dermatopathol, 23, 5.

10) Goel, R., Centos, M. J., et al. (2003, Nov). Widespread metastatic eccrine porocarcinoma . J. Am Acad. Dermatol., 49, S252-4.

11) Vendeweyer, E., Renate, C., et al. (2006). Ecrine porocarcinoma: A case reporte. Acta Chi. Belg., 106, 121-123.

Published

2020-11-12